Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens ASA, van de Glind G, Banaschewski T, Barta C, Begeman A, Casas M, Crunelle CL, Daigre Blanco C, Dalsgaard S, Demetrovics Z, den Boer J, Dom G, Eapen V, Faraone SV, Franck J, González RA, Grau-López L, Groenman AP, Hemphälä M, Icick R, Johnson B, Kaess M, Kapitány-Fövény M, Kasinathan JG, Kaye SS, Kiefer F, Konstenius M, Levin FR, Luderer M, Martinotti G, Matthys FIA, Meszaros G, Moggi F, Munasur-Naidoo AP, Post M, Rabinovitz S, Ramos-Quiroga JA, Sala R, Shafi A, Slobodin O, Staal WG, Thomasius R, Truter I, van Kernebeek MW, Velez-Pastrana MC, Vollstädt-Klein S, Vorspan F, Young JT, Yule A, van den Brink W, Hendriks V. Özgen H, et al. Among authors: holtmann m. Eur Addict Res. 2020;26(4-5):223-232. doi: 10.1159/000508385. Epub 2020 Jul 7. Eur Addict Res. 2020. PMID: 32634814 Free article.
[International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens ASA, van de Glind G, Banaschewski T, Barta C, Begeman A, Casas M, Crunelle CL, Daigre Blanco C, Dalsgaard S, Demetrovics Z, den Boer J, Dom G, Eapen V, Faraone SV, Franck J, González RA, Grau-López L, Groenman AP, Hemphälä M, Icick R, Johnson B, Kaess M, Kapitány-Fövény M, Kasinathan JG, Kaye SS, Kiefer F, Konstenius M, Levin FR, Luderer M, Martinotti G, Matthys FIA, Meszaros G, Moggi F, Munasur-Naidoo AP, Post M, Rabinovitz S, Ramos-Quiroga JA, Sala R, Shafi A, Slobodin O, Staal WG, Thomasius R, Truter I, van Kernebeek MW, Velez-Pastrana MC, Vollstädt-Klein S, Vorspan F, Young JT, Yule A, van den Brink W, Hendriks V. Özgen H, et al. Among authors: holtmann m. Z Kinder Jugendpsychiatr Psychother. 2021 Jan;50(1):54-67. doi: 10.1024/1422-4917/a000828. Epub 2021 Aug 16. Z Kinder Jugendpsychiatr Psychother. 2021. PMID: 34397296 Free article. German.
Onset and Severity of Early Disruptive Behavioral Disorders in Treatment-Seeking Substance Use Disorder Patients with and without Attention-Deficit/Hyperactivity Disorder.
González RA, Vélez-Pastrana MC, Blankers M, Bäcker A, Konstenius M, Holtmann M, Levin FR, Noack M, Kaye S, Demetrovics Z, van de Glind G, van den Brink W, Schellekens A; ICASA Group. González RA, et al. Among authors: holtmann m. Eur Addict Res. 2020;26(4-5):211-222. doi: 10.1159/000508653. Epub 2020 Jun 26. Eur Addict Res. 2020. PMID: 32594079
Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
Sobanski E, Banaschewski T, Asherson P, Buitelaar J, Chen W, Franke B, Holtmann M, Krumm B, Sergeant J, Sonuga-Barke E, Stringaris A, Taylor E, Anney R, Ebstein RP, Gill M, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Steinhausen HC, Faraone SV. Sobanski E, et al. Among authors: holtmann m. J Child Psychol Psychiatry. 2010 Aug;51(8):915-23. doi: 10.1111/j.1469-7610.2010.02217.x. Epub 2010 Feb 1. J Child Psychol Psychiatry. 2010. PMID: 20132417
Attention-Deficit/Hyperactivity Disorder.
Banaschewski T, Becker K, Döpfner M, Holtmann M, Rösler M, Romanos M. Banaschewski T, et al. Among authors: holtmann m. Dtsch Arztebl Int. 2017 Mar 3;114(9):149-159. doi: 10.3238/arztebl.2017.0149. Dtsch Arztebl Int. 2017. PMID: 28351467 Free PMC article. Review.
[Substance-related disorders in adolescence and young adulthood].
Thomasius R, Arnaud N, Holtmann M, Kiefer F. Thomasius R, et al. Among authors: holtmann m. Z Kinder Jugendpsychiatr Psychother. 2020 Nov;48(6):448-452. doi: 10.1024/1422-4917/a000725. Epub 2020 Mar 24. Z Kinder Jugendpsychiatr Psychother. 2020. PMID: 32208050 Review. German.
Neurofeedback in autism spectrum disorders.
Holtmann M, Steiner S, Hohmann S, Poustka L, Banaschewski T, Bölte S. Holtmann M, et al. Dev Med Child Neurol. 2011 Nov;53(11):986-93. doi: 10.1111/j.1469-8749.2011.04043.x. Epub 2011 Jul 14. Dev Med Child Neurol. 2011. PMID: 21752020 Free article. Review.
Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)-Study protocol of a randomised controlled trial within the consortium ESCAlife.
Geissler J, Jans T, Banaschewski T, Becker K, Renner T, Brandeis D, Döpfner M, Dose C, Hautmann C, Holtmann M, Jenkner C, Millenet S, Romanos M. Geissler J, et al. Among authors: holtmann m. Trials. 2018 Apr 27;19(1):254. doi: 10.1186/s13063-018-2635-2. Trials. 2018. PMID: 29703226 Free PMC article.
258 results